192 related articles for article (PubMed ID: 36708234)
21. "Spice"-related deaths in and around Munich, Germany: A retrospective look at the role of synthetic cannabinoid receptor agonists in our post-mortem cases over a seven-year period (2014-2020).
Groth O; Roider G; Angerer V; Schäper J; Graw M; Musshoff F; Auwärter V
Int J Legal Med; 2023 Jul; 137(4):1059-1069. PubMed ID: 37072496
[TBL] [Abstract][Full Text] [Related]
22. Synthetic Cannabinoid Receptor Agonists Detection Using Fluorescence Spectral Fingerprinting.
May B; Naqi HA; Tipping M; Scott J; Husbands SM; Blagbrough IS; Pudney CR
Anal Chem; 2019 Oct; 91(20):12971-12979. PubMed ID: 31580647
[TBL] [Abstract][Full Text] [Related]
23. Does cannabis testing in the military drive synthetic cannabinoid use? Self-reported use motivations among justice-involved veterans.
Santangelo O; Baldwin JM; Stogner J
Int J Drug Policy; 2022 Aug; 106():103756. PubMed ID: 35738030
[TBL] [Abstract][Full Text] [Related]
24. Activity-based detection of synthetic cannabinoid receptor agonists in plant materials.
Timmerman A; Balcaen M; Coopman V; Degreef M; Pottie E; Stove CP
Harm Reduct J; 2024 Jul; 21(1):127. PubMed ID: 38951904
[TBL] [Abstract][Full Text] [Related]
25. Clinical withdrawal symptom profile of synthetic cannabinoid receptor agonists and comparison of effects with high potency cannabis.
Craft S; Ferris JA; Barratt MJ; Maier LJ; Lynskey MT; Winstock AR; Freeman TP
Psychopharmacology (Berl); 2022 May; 239(5):1349-1357. PubMed ID: 34533608
[TBL] [Abstract][Full Text] [Related]
26. Cannabinoid receptor activation potential of the next generation, generic ban evading OXIZID synthetic cannabinoid receptor agonists.
Deventer MH; Van Uytfanghe K; Vinckier IMJ; Reniero F; Guillou C; Stove CP
Drug Test Anal; 2022 Sep; 14(9):1565-1575. PubMed ID: 35560866
[TBL] [Abstract][Full Text] [Related]
27. Insights into biased signaling at cannabinoid receptors: synthetic cannabinoid receptor agonists.
Wouters E; Walraed J; Banister SD; Stove CP
Biochem Pharmacol; 2019 Nov; 169():113623. PubMed ID: 31472128
[TBL] [Abstract][Full Text] [Related]
28. Interaction of Synthetic Cannabinoid Receptor Agonists with Cannabinoid Receptor I: Insights into Activation Molecular Mechanism.
Gavryushov S; Bashilov A; Cherashev-Tumanov KV; Kuzmich NN; Burykina TI; Izotov BN
Int J Mol Sci; 2023 Oct; 24(19):. PubMed ID: 37834323
[TBL] [Abstract][Full Text] [Related]
29. The use and effects of synthetic cannabinoid receptor agonists by New South Wales cannabis treatment clients.
Jackson MA; Brown AL; Johnston J; Clancy R; McGregor I; Bruno R; Lintzeris N; Montebello M; Luksza J; Bowman J; Phung N; Allsop D; Dunlop AJ
J Cannabis Res; 2021 Jul; 3(1):33. PubMed ID: 34311790
[TBL] [Abstract][Full Text] [Related]
30. Fourth Generation of Synthetic Cannabinoid Receptor Agonists: A Review on the Latest Insights.
Malaca S; Busardò FP; Nittari G; Sirignano A; Ricci G
Curr Pharm Des; 2022; 28(32):2603-2617. PubMed ID: 34781870
[TBL] [Abstract][Full Text] [Related]
31. Synthesis and
Cannaert A; Sparkes E; Pike E; Luo JL; Fang A; Kevin RC; Ellison R; Gerona R; Banister SD; Stove CP
ACS Chem Neurosci; 2020 Dec; 11(24):4434-4446. PubMed ID: 33253529
[TBL] [Abstract][Full Text] [Related]
32. Pharmacology, prevalence in Germany, and analytical data of cyclobutylmethyl- and norbornylmethyl-type synthetic cannabinoid receptor agonists.
Pulver B; Riedel J; Schönberger T; Halter S; Lucas T; Opatz T; Grafinger KE; Scheu M; Zschiesche A; Pütz M; Pützer K; Westphal F; Auwärter V
Drug Test Anal; 2023 Apr; 15(4):408-425. PubMed ID: 36541839
[TBL] [Abstract][Full Text] [Related]
33. Functional evaluation of carboxy metabolites of synthetic cannabinoid receptor agonists featuring scaffolds based on L-valine or L-tert-leucine.
Wouters E; Mogler L; Cannaert A; Auwärter V; Stove C
Drug Test Anal; 2019 Aug; 11(8):1183-1191. PubMed ID: 31021521
[TBL] [Abstract][Full Text] [Related]
34. Evolution of clinical characteristics and outcomes of synthetic cannabinoid receptor agonist exposure in the United States: analysis of National Poison Data System data from 2010 to 2015.
Cordeiro SK; Daro RC; Seung H; Klein-Schwartz W; Kim HK
Addiction; 2018 Oct; 113(10):1850-1861. PubMed ID: 29806885
[TBL] [Abstract][Full Text] [Related]
35. Subtle Structural Modification of a Synthetic Cannabinoid Receptor Agonist Drastically Increases its Efficacy at the CB1 Receptor.
Yano H; Chitsazi R; Lucaj C; Tran P; Hoffman AF; Baumann MH; Lupica CR; Shi L
ACS Chem Neurosci; 2023 Nov; 14(21):3928-3940. PubMed ID: 37847546
[TBL] [Abstract][Full Text] [Related]
36. Systematic evaluation of a panel of 30 synthetic cannabinoid receptor agonists structurally related to MMB-4en-PICA, MDMB-4en-PINACA, ADB-4en-PINACA, and MMB-4CN-BUTINACA using a combination of binding and different CB
Pike E; Grafinger KE; Cannaert A; Ametovski A; Luo JL; Sparkes E; Cairns EA; Ellison R; Gerona R; Stove CP; Auwärter V; Banister SD
Drug Test Anal; 2021 Jul; 13(7):1383-1401. PubMed ID: 33787091
[TBL] [Abstract][Full Text] [Related]
37. "Walking the nitrogen around the ring": Chemical synthesis and spectroscopic characterization of novel 4-, 5-, 6-, and 7-azaindazole analogs of the synthetic cannabinoid receptor agonist MDMB-PINACA.
Alam RM; Keating JJ
Drug Test Anal; 2022 Feb; 14(2):277-297. PubMed ID: 34654062
[TBL] [Abstract][Full Text] [Related]
38. In vitro determination of the efficacy of illicit synthetic cannabinoids at CB
Sachdev S; Vemuri K; Banister SD; Longworth M; Kassiou M; Santiago M; Makriyannis A; Connor M
Br J Pharmacol; 2019 Dec; 176(24):4653-4665. PubMed ID: 31412133
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of monoamine oxidase A and B activities by imidazol(ine)/guanidine drugs, nature of the interaction and distinction from I2-imidazoline receptors in rat liver.
Ozaita A; Olmos G; Boronat MA; Lizcano JM; Unzeta M; García-Sevilla JA
Br J Pharmacol; 1997 Jul; 121(5):901-12. PubMed ID: 9222546
[TBL] [Abstract][Full Text] [Related]
40. Modulation of human T-type calcium channels by synthetic cannabinoid receptor agonists in vitro.
Bladen C; Mirlohi S; Santiago M; Longworth M; Kassiou M; Banister S; Connor M
Neuropharmacology; 2021 Apr; 187():108478. PubMed ID: 33600843
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
